95 related articles for article (PubMed ID: 11397470)
1. The widening role of statins: RAS signal transduction and drug-induced cytotoxicity in human leukemia: a commentary to 'interaction of cytosine arabinoside and lovastatin in human leukemia cells'.
Braess J; Hiddemann W
Leuk Res; 2001 Aug; 25(8):661-3. PubMed ID: 11397470
[No Abstract] [Full Text] [Related]
2. Interaction of cytosine arabinoside and lovastatin in human leukemia cells.
Holstein SA; Hohl RJ
Leuk Res; 2001 Aug; 25(8):651-60. PubMed ID: 11397469
[TBL] [Abstract][Full Text] [Related]
3. Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.
Stirewalt DL; Appelbaum FR; Willman CL; Zager RA; Banker DE
Leuk Res; 2003 Feb; 27(2):133-45. PubMed ID: 12526919
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
5. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
8. The role of purine analogue combinations in the management of acute leukemias.
Frewin RJ; Johnson SA
Hematol Oncol; 2001 Dec; 19(4):151-7. PubMed ID: 11754391
[TBL] [Abstract][Full Text] [Related]
9. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
Dimitroulakos J; Lorimer IA; Goss G
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4426s-4431s. PubMed ID: 16857822
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.
Laezza C; Mazziotti G; Fiorentino L; Gazzerro P; Portella G; Gerbasio D; Carella C; Matarese G; Bifulco M
J Mol Med (Berl); 2006 Nov; 84(11):967-73. PubMed ID: 16947002
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
12. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
Issat T; Nowis D; Legat M; Makowski M; Klejman MP; Urbanski J; Skierski J; Koronkiewicz M; Stoklosa T; Brzezinska A; Bil J; Gietka J; Jakóbisiak M; Golab J
Int J Oncol; 2007 Jun; 30(6):1413-25. PubMed ID: 17487362
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells.
Issat T; Nowis D; Jakóbisiak M; Golab J
Oncol Rep; 2004 Dec; 12(6):1371-5. PubMed ID: 15547765
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
Sora MK; Kruszewski AA; Stokłosa T; Czyzyk J; Lasek W; Malejczyk J; Jakóbisiak M
Arch Immunol Ther Exp (Warsz); 1994; 42(4):269-74. PubMed ID: 7487365
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin.
Jaster R; Brock P; Sparmann G; Emmrich J; Liebe S
Biochem Pharmacol; 2003 Apr; 65(8):1295-303. PubMed ID: 12694870
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction of lovastatin and paclitaxel in human cancer cells.
Holstein SA; Hohl RJ
Mol Cancer Ther; 2001 Dec; 1(2):141-9. PubMed ID: 12467231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
